ARTICLE | Clinical News
Enbrel etanercept soluble tumor necrosis factor receptor regulatory update
April 17, 2000 7:00 AM UTC
The FDA's Arthritis Advisory Committee voted 7-2 to recommend approval of Enbrel to improve the signs and symptoms of early stage rheumatoid arthritis (RA), and unanimously recommended approval of Enb...